Company Profiles

driven by the PitchBook Platform

Karos Pharmaceuticals

Description

Developer of pharmaceuticals for bone diseases. The company is developing oral drugs designed to promote bone growth to treat severe osteoporosis.

2009

Founded

PRIVATE

Status

1-10

Employees

Conv. Debt

Latest Deal Type

$26M

Total Amount Raised

3

Investors

Description

Developer of pharmaceuticals for bone diseases. The company is developing oral drugs designed to promote bone growth to treat severe osteoporosis.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

5 Science Park Suite 2 New Haven, CT 06511United States +1 (203) 535-0540
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Karos Pharmaceuticals's full profile, request a free trial.

Karos Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Karos Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Karos Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
New Leaf Venture PartnersVenture CapitalMinority000 0000000 0000
Partnership Fund for New York CityVenture CapitalMinority000 0000000 0000
TPG BiotechPE/BuyoutMinority000 0000000 0000
New Leaf Venture Partners Venture Capital
Partnership Fund for New York City Venture Capital
TPG Biotech PE/Buyout

Karos Pharmaceuticals Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Stéphane De Lombaert Ph.DChief Operating Officer & Head of Chemistry
Vishwas Paralkar Ph.DChief Scientific Officer & Senior Vice President, Biology
Robert Aiello Ph.DSenior Director
Stéphane De Lombaert Ph.D Chief Operating Officer & Head of Chemistry
Vishwas Paralkar Ph.D Chief Scientific Officer & Senior Vice President, Biology
Robert Aiello Ph.D Senior Director

Karos Pharmaceuticals Board Members (4)

NameRepresentingRoleSinceContact
Info
Cayce DentonTPG BiotechBoard Member000 0000
Geoffrey Duyk Ph.DTPG BiotechBoard Member000 0000
Isaac Manke Ph.DNew Leaf Venture PartnersBoard Member000 0000
Philippe Chambon MDNew Leaf Venture PartnersBoard Member000 0000
Cayce Denton Board Member TPG Biotech
Geoffrey Duyk Ph.D Board Member TPG Biotech
Isaac Manke Ph.D Board Member New Leaf Venture Partners
Philippe Chambon MD Board Member New Leaf Venture Partners
Request full access to PitchBook